000169892 001__ 169892
000169892 005__ 20240229133659.0
000169892 0247_ $$2doi$$a10.1164/rccm.202102-0278OC
000169892 0247_ $$2pmid$$apmid:34283704
000169892 0247_ $$2ISSN$$a0003-0805
000169892 0247_ $$2ISSN$$a0096-0381
000169892 0247_ $$2ISSN$$a0096-039X
000169892 0247_ $$2ISSN$$a1073-449X
000169892 0247_ $$2ISSN$$a1535-4970
000169892 0247_ $$2ISSN$$a2376-3752
000169892 0247_ $$2altmetric$$aaltmetric:110057170
000169892 037__ $$aDKFZ-2021-01626
000169892 041__ $$aEnglish
000169892 082__ $$a610
000169892 1001_ $$00000-0001-6941-8315$$aStahl, Mirjam$$b0
000169892 245__ $$aMagnetic Resonance Imaging Detects Progression of Lung Disease and Impact of Newborn Screening in Preschool Children with Cystic Fibrosis.
000169892 260__ $$aNew York, NY$$bAmerican Thoracic Society$$c2021
000169892 3367_ $$2DRIVER$$aarticle
000169892 3367_ $$2DataCite$$aOutput Types/Journal article
000169892 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1642168745_14743
000169892 3367_ $$2BibTeX$$aARTICLE
000169892 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000169892 3367_ $$00$$2EndNote$$aJournal Article
000169892 500__ $$a2021 Oct 15;204(8):943-953
000169892 520__ $$aPrevious cross-sectional studies demonstrated that chest magnetic resonance imaging (MRI) is sensitive to detect early lung disease in infants and preschool children with cystic fibrosis (CF) without radiation exposure. However, the ability of MRI to detect progression of lung disease and the impact of early diagnosis in preschool children with CF remains unknown.To investigate the potential of MRI to detect progression of early lung disease and impact of early diagnosis by CF newborn screening (NBS) in preschool children with CF.Annual MRI was performed from diagnosis over four years in a cohort of 96 preschool children with CF (age 0-4 yr) that were concurrently diagnosed based on NBS (n=28) or clinical symptoms (n=68). MRI scans were evaluated using a dedicated morphofunctional score and the relationship between longitudinal MRI scores and respiratory symptoms, pulmonary exacerbations, upper airway microbiology and mode of diagnosis were determined.The MRI global score increased in the total cohort of children with CF during preschool years (P<0.001) which was associated with cough, pulmonary exacerbations (P<0.0001), and detection of Staphylococcus aureus and Haemophilus influenzae (P<0.05). MRI-defined abnormalities in lung morphology, especially airway wall thickening/bronchiectasis, were lower in NBS compared to clinically diagnosed children with CF throughout the observation period (P<0.01).MRI detected progression of early lung disease and benefits of early diagnosis by NBS in preschool children with CF. These findings support MRI as sensitive outcome measure for diagnostic monitoring and early intervention trials in preschool children with CF.
000169892 536__ $$0G:(DE-HGF)POF4-315$$a315 - Bildgebung und Radioonkologie (POF4-315)$$cPOF4-315$$fPOF IV$$x0
000169892 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
000169892 650_7 $$2Other$$acystic fibrosis
000169892 650_7 $$2Other$$aearly lung disease
000169892 650_7 $$2Other$$amagnetic resonance imaging
000169892 650_7 $$2Other$$anewborn screening
000169892 650_7 $$2Other$$anon-invasive monitoring
000169892 7001_ $$aSteinke, Eva$$b1
000169892 7001_ $$00000-0002-1666-8924$$aGraeber, Simon Y$$b2
000169892 7001_ $$aJoachim, Cornelia$$b3
000169892 7001_ $$aSeitz, Christoph$$b4
000169892 7001_ $$aKauczor, Hans-Ulrich$$b5
000169892 7001_ $$aEichinger, Monika$$b6
000169892 7001_ $$aHämmerling, Susanne$$b7
000169892 7001_ $$aSommerburg, Olaf$$b8
000169892 7001_ $$0P:(DE-He78)40da88c1e07a6ce8bf1d138b6215471f$$aWielpütz, Mark Oliver$$b9$$udkfz
000169892 7001_ $$00000-0002-4057-2199$$aMall, Marcus A$$b10
000169892 773__ $$0PERI:(DE-600)1468352-0$$a10.1164/rccm.202102-0278OC$$gp. rccm.202102-0278OC$$n8$$p943-953$$tAmerican journal of respiratory and critical care medicine$$v204$$x1535-4970$$y2021
000169892 909CO $$ooai:inrepo02.dkfz.de:169892$$pVDB
000169892 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)40da88c1e07a6ce8bf1d138b6215471f$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000169892 9131_ $$0G:(DE-HGF)POF4-315$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vBildgebung und Radioonkologie$$x0
000169892 9130_ $$0G:(DE-HGF)POF3-315$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vImaging and radiooncology$$x0
000169892 9141_ $$y2021
000169892 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-01-26
000169892 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-01-26
000169892 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2021-01-26
000169892 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-01-26
000169892 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2021-01-26
000169892 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-26
000169892 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2021-01-26
000169892 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2021-01-26
000169892 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-01-26
000169892 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-26
000169892 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-01-26
000169892 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bAM J RESP CRIT CARE : 2019$$d2021-01-26
000169892 915__ $$0StatID:(DE-HGF)9915$$2StatID$$aIF >= 15$$bAM J RESP CRIT CARE : 2019$$d2021-01-26
000169892 9201_ $$0I:(DE-He78)E010-20160331$$kE010$$lE010 Radiologie$$x0
000169892 980__ $$ajournal
000169892 980__ $$aVDB
000169892 980__ $$aI:(DE-He78)E010-20160331
000169892 980__ $$aUNRESTRICTED